These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
466 related items for PubMed ID: 8707283
1. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283 [Abstract] [Full Text] [Related]
2. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection. Abayli B, Canataroğlu A, Akkiz H. Turk J Gastroenterol; 2003 Mar; 14(1):7-11. PubMed ID: 14593531 [Abstract] [Full Text] [Related]
3. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Fan XG, Liu WE, Li CZ, Wang ZC, Luo LX, Tan DM, Hu GL, Zhang Z. Mediators Inflamm; 1998 Mar; 7(4):295-7. PubMed ID: 9792341 [Abstract] [Full Text] [Related]
5. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections. El-Kady IM, Lotfy M, Badra G, El-Masry S, Waked I. Scand J Immunol; 2005 Jan; 61(1):87-91. PubMed ID: 15644127 [Abstract] [Full Text] [Related]
6. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children. Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A. Med Sci Monit; 2000 Jan; 6(5):964-70. PubMed ID: 11208439 [Abstract] [Full Text] [Related]
7. Long-term follow-up after successful interferon therapy of acute hepatitis C. Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091 [Abstract] [Full Text] [Related]
8. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Hepatology; 1996 Oct; 24(4):759-65. PubMed ID: 8855173 [Abstract] [Full Text] [Related]
9. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha. Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G. Rev Invest Clin; 2002 Oct; 54(1):41-50. PubMed ID: 11995406 [Abstract] [Full Text] [Related]
10. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease. Gigi E, Raptopoulou-Gigi M, Kalogeridis A, Masiou S, Orphanou E, Vrettou E, Lalla TH, Sinakos E, Tsapas V. J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198 [Abstract] [Full Text] [Related]
11. Determination of serum cytokines in individuals with HCV infection. Fan X, Liu W, Li C. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):145-7. PubMed ID: 11503046 [Abstract] [Full Text] [Related]
12. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Grüngreiff K, Reinhold D, Ansorge S. Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433 [Abstract] [Full Text] [Related]
13. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Zeuzem S, Schmidt JM, Lee JH, Rüster B, Roth WK. Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865 [Abstract] [Full Text] [Related]
14. Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance. Casanovas-Taltavull T, Ercilla MG, Gonzalez CP, Gil E, Viñas O, Cañas C, Casanova A, Figueras J, Serrano T, Casais LA. Liver Transpl; 2004 May; 10(5):584-94. PubMed ID: 15108249 [Abstract] [Full Text] [Related]
15. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, Cabrera R, Liu C, Davis GL. Hepatology; 2003 Oct; 38(4):859-68. PubMed ID: 14512873 [Abstract] [Full Text] [Related]
16. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover. Zeuzem S, Schmidt JM, Lee JH, von Wagner M, Teuber G, Roth WK. Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119 [Abstract] [Full Text] [Related]
17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R. Clin Ter; 2006 Jul; 157(4):377-86. PubMed ID: 17051976 [Abstract] [Full Text] [Related]
18. [Predictor of effect of interferon-alpha on patients with hepatitis B: Th1/Th2 type cytokines]. Xing T, Zhang L, Lu Q. Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):268-70. PubMed ID: 11798769 [Abstract] [Full Text] [Related]
19. Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Martín J, de Sequera P, Quiroga JA, Rico M, Fernández M, Arocena C, Caramelo C, Carreño V. Cytokine; 2000 Aug; 12(8):1248-52. PubMed ID: 10930306 [Abstract] [Full Text] [Related]
20. Th1/Th2 type cytokines in hepatitis B patients treated with interferon-alpha. Xing T, Zhang L, Lu Q, Hou J, Feng X, Luo K. Chin Med J (Engl); 2001 Sep; 114(9):921-4. PubMed ID: 11780382 [Abstract] [Full Text] [Related] Page: [Next] [New Search]